This brief offers advice on ways to make the case—both to your Country Coordinating Mechanism (CCM) and in your Global Fund proposal itself— that hepatitis C matters for the HIV response. The Global Fund has indicated its willingness to support hepatitis C-related prevention, treatment, and advocacy efforts. However, that support can only be provided if countries request it and provide strong evidence and arguments in their proposals.
To effectively address hepatitis C among people living with HIV and people who inject drugs, it is recommended to focus on: